![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 08, 2020 3:08:42 PM
We can assume that phase III trial is pretty close to complete now, so why open up a new trial site unless it is to be used for the NIH trial as well? I could be completely crazy.. but it kind of makes sense.
We are pleased to announce we’ve added MedStar Washington Hospital Center @MedStarWHC to our study sites participating in our Phase 3 study of lenzilumab in patients with COVID-19.
— Humanigen, Inc. (@humanigen) October 8, 2020
Please visit our website to locate a clinical site near you.https://t.co/nDPb48IacU$HGEN
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM